Continuous Glucose Monitoring (CGM) technology has fundamentally changed the way individuals manage diabetes. By providing real-time data on blood glucose levels, CGMs empower users to make informed decisions about their health, leading to better outcomes and greater control over diabetes. The journey from the Dexcom G7 to the revolutionary Dexcom Stelo glucose biosensor system marks a significant evolution in this technology, setting new standards for accuracy, comfort, and integration. In this blog, we’ll explore the advancements from the Dexcom G7 to Stelo, why the Stelo is considered a breakthrough in diabetes care, and how Heald’s holistic approach can further enhance your management of diabetes.

The Journey of CGM: From Early Devices to Dexcom G7

Continuous Glucose Monitoring (CGM) technology began with devices that were bulky, required frequent calibrations, and provided limited data that could only be accessed in clinical settings. These early CGMs were a far cry from the sleek, user-friendly devices available today, but they laid the groundwork for continuous glucose monitoring, offering a glimpse into the potential of real-time glucose data in managing diabetes.

• Early CGMs: Early devices were primarily used by healthcare providers to monitor glucose trends over time. They required frequent fingerstick calibrations and offered limited data, which could only be accessed during clinical visits.

• Dexcom G6: The Dexcom G6 represented a significant leap forward, offering users the ability to monitor their glucose levels continuously without the need for routine fingerstick calibrations. It featured a slimmer sensor design and improved accuracy, making it a popular choice for individuals managing diabetes.

• Dexcom G7 (2022): The Dexcom G7 built on the success of its predecessors, introducing a smaller, more discreet sensor with faster warm-up times and enhanced accuracy. The G7 also integrated seamlessly with smartphones and smartwatches, allowing users to access their glucose data in real-time from their devices. This level of convenience and accuracy made the G7 a game-changer in the world of CGM technology.

Dexcom G7 vs. Dexcom Stelo: A Comparative Look

While the Dexcom G7 set a new standard in CGM technology, the Dexcom Stelo represents the next step in the evolution of glucose monitoring. Here’s a closer look at how these two devices compare:

• Sensor Size and Design: The Dexcom Stelo features an even smaller and more comfortable sensor than the G7, making it virtually invisible under clothing. This advancement in design not only improves comfort but also increases adherence, as users are more likely to consistently wear a device that is unobtrusive and comfortable.

• Accuracy and Response Time: The Dexcom Stelo offers improved accuracy and faster response times compared to the G7. This means that users receive more reliable data, allowing them to make quicker, more informed decisions about their diabetes management. Whether adjusting insulin doses or making dietary changes, having accurate, real-time data is crucial for effective diabetes care.

• Extended Wear Time: While the G7 sensor lasts for up to 10 days, the Stelo extends this to a full 14 days, reducing the frequency of sensor changes and offering greater convenience. This extended wear time is particularly beneficial for those who lead busy lives and want to minimize disruptions to their daily routine.

• Advanced Connectivity: The Stelo integrates seamlessly with advanced AI-driven platforms like Heald, offering users predictive alerts, personalized insights, and tailored recommendations based on their continuous glucose data. This level of connectivity enhances the user experience, making it easier to stay on top of diabetes management.